Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $26.74 USD
Change Today -1.39 / -4.94%
Volume 1.2M
MR On Other Exchanges
Symbol
Exchange
New York
Singapore
Mexico
As of 2:44 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

mindray medical intl ltd-adr (MR) Snapshot

Open
$28.03
Previous Close
$28.13
Day High
$28.09
Day Low
$26.62
52 Week High
03/5/15 - $33.83
52 Week Low
01/6/15 - $25.90
Market Cap
3.1B
Average Volume 10 Days
316.2K
EPS TTM
$1.63
Shares Outstanding
88.2M
EX-Date
03/17/15
P/E TM
16.4x
Dividend
$0.40
Dividend Yield
1.50%
Current Stock Chart for MINDRAY MEDICAL INTL LTD-ADR (MR)

mindray medical intl ltd-adr (MR) Related Businessweek News

View More BusinessWeek News

mindray medical intl ltd-adr (MR) Details

Mindray Medical International Limited develops, manufactures, and markets medical devices worldwide. The company operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. The Patient Monitoring and Life Support Products segment offers monitoring devices that track the physiological parameters of patients, such as heart rate, blood pressure, respiration, and temperature. Its products include single and multiple-parameter monitors; mobile and portable multifunction monitors; central stations that can collect and display multiple patient data on a single screen; electro-cardiogram monitoring devices; and veterinary monitoring devices. This segment also provides anesthesia machines; defibrillators; surgical equipment, including surgical beds, and surgical lights ceiling pendants; syringes and infusion pumps; and ventilators. The In-Vitro Diagnostic Products segment provides data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment; and in-vitro diagnostic products for laboratories, clinics, and hospitals to perform analysis to detect and quantify substances in patient samples. Its product portfolio consists of hematology analysis, biochemistry analysis, immunoassay analysis, flow cytometric analysis, coagulation analysis, urine sediment analysis and microbiology analysis; and reagents used in in-vitro diagnostic products. The Medical Imaging Systems segment offers ultrasound systems used in medical fields, such as urology, gynecology, obstetrics, and cardiology; digital radiography systems; and magnetic resonance imaging systems. The company also provides orthopedic products, endoscope devices, and healthcare IT solutions. It markets and sells its products through distributors, as well as directly to hospitals and government agencies. The company was founded in 1991 and is headquartered in Shenzhen, the People’s Republic of China.

8,200 Employees
Last Reported Date: 05/11/15
Founded in 1991

mindray medical intl ltd-adr (MR) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

mindray medical intl ltd-adr (MR) Key Developments

Mindray Medical International Limited Announces Unaudited Consolidated Financial Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Year 2015

Mindray Medical International Limited announced unaudited consolidated financial results for the first quarter ended March 31, 2015. For the quarter, the company reported net revenues increased 2.9% year-over-year to $272.5 million. Operating income was $30.9 million against $31.3 million a year ago. Non-GAAP operating income was $39.0 million against $42.3 million a year ago. EBITDA was $45.5 million against $46.0 million a year ago. Net income was $32.2 million against $35.6 million a year ago. Diluted earnings per share was $0.27 against $0.30 a year ago. Non-GAAP net income was $39.5 million against $46.1 million a year ago. Non-GAAP Diluted EPS was $0.33 against $0.39 a year ago. Net cash generated from operating activities $37.0 million against $19.666 million a year ago. Income before income taxes and non-controlling interests was $42,120,000 against $41,461,000 a year ago. Capital expenditures was $30,780,000 against $27,875,000 a year ago. The company continues to expect its full year 2015 net revenues to grow by a mid-single digit percentage over its full year 2014 net revenues. Previous guidance for full year 2015 non-GAAP net income is being revised to reflect the impact of the newly announced employee incentive and talent retention program, as well as pricing pressure as a result of rising competition. Assuming the related 2015 payments are distributed half in equity based compensation and half in cash, Mindray forecasts its full year 2015 non-GAAP net income to decrease by a high-teens percentage over its full year 2014 non-GAAP net income. The company continues to expect its capital expenditure for full year 2015 to be around $150 million.

Mindray Medical International Limited to Report Q1, 2015 Results on May 11, 2015

Mindray Medical International Limited announced that they will report Q1, 2015 results at 5:00 PM, China Standard Time on May 11, 2015

Mindray Medical International Limited, Q1 2015 Earnings Call, May 12, 2015

Mindray Medical International Limited, Q1 2015 Earnings Call, May 12, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MR:US $26.74 USD -1.39

MR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CAS Medical Systems Inc $1.27 USD -0.0401
Hutchinson Technology Inc $1.61 USD +0.01
Masimo Corp $38.37 USD -0.24
OSI Systems Inc $70.55 USD -0.29
Sysmex Corp ¥7,410 JPY -180.00
View Industry Companies
 

Industry Analysis

MR

Industry Average

Valuation MR Industry Range
Price/Earnings 17.6x
Price/Sales 2.5x
Price/Book 2.1x
Price/Cash Flow 17.4x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MINDRAY MEDICAL INTL LTD-ADR, please visit www.mindray.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.